![Scholar Rock Holdings Corporation](/common/images/company/N_SRRK.png)
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States.... Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Show more
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious...
Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other...
- SRK-439, a myostatin inhibitor, is part of Scholar Rock’s industry-leading anti-myostatin portfolio - Obesity program continues to progress, with first participants dosed in Phase 2 EMBRAZE...
Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other...
Promising objective response rates (ORR) were observed in multiple tumor types in anti-PD-(L)1 resistant patients Analysis of baseline biomarker data in clear cell renal cell carcinoma (ccRCC...
- Updated safety and efficacy results on SRK-181 will be featured in an oral presentation on Monday, June 3rd, at 1:50 p.m CDT/2:50 p.m. EDT - Company will host conference call to discuss the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.47 | 5.34698521047 | 8.79 | 9.86 | 8.5 | 749720 | 9.11415077 | CS |
4 | 0.8 | 9.45626477541 | 8.46 | 9.86 | 7.53 | 845772 | 8.60310308 | CS |
12 | -6.41 | -40.9061901723 | 15.67 | 15.825 | 7.53 | 947387 | 9.91082753 | CS |
26 | -5.73 | -38.2254836558 | 14.99 | 17.9 | 7.53 | 859403 | 12.64094761 | CS |
52 | 2.7 | 41.1585365854 | 6.56 | 21.17 | 5.93 | 804330 | 12.57641119 | CS |
156 | -23.39 | -71.6385911179 | 32.65 | 44.95 | 4.325 | 538158 | 11.63758023 | CS |
260 | -3.02 | -24.5928338762 | 12.28 | 70 | 4.325 | 486326 | 19.42717406 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.